|
|
Article: ACRIN TRIAL EVALUATES IMAGING FOR STAGING CERVICAL CANCER.
- Article from:
- Imaging Update
- Article date:
- November 1, 2007
CopyrightCOPYRIGHT 2007 Worldwide Videotex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
A new study conducted by the American College of Radiology Imaging Network (ACRIN(r)) and the Gynecologic Oncology Group (GOG) is now underway to evaluate the ability of positron emission tomography (PET)/computed tomography (CT) with Fluorodeoxyglucose (FDG-PET/CT) and MRI with the contrast agent Combidex (ferumoxtran-10) to identify pelvic and abdominal lymph node metastases in patients with locoregionally advanced cervical cancer.
According to study investigators, FDG-PET/CT and Combidex MRI offer promise for finding cancers that may presently go undiagnosed. "Currently, we try to diagnose lymph node metastases by size. This method has low specificity and low ...